SNAPC5

Across TCGA pan-cancer cohorts, SNAPC5 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SNAPC5’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where SNAPC5 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SNAPC5 is over-expressed in tumor, although a few such as LUAD and PDAC show the opposite, repressed pattern.

CCRCC, LUAD, and LSCC are the cancer types where SNAPC5 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNAPC5 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	III,IV	+0.746	<.001	10	view →
LUAD	All	All	−0.341	<.001	7	view →
LSCC	Male	II,III,IV	+0.351	<.001	5	view →
PDAC	All	II,III,IV	−0.852	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SNAPC5–CCRCC

Open the CCRCC breakdown →